We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $12.4B
1-Year Est. Return 64.17%
This Fund
S&P 500
This Quarter Est. Return
+1.43%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$10.8B
AUM Growth
-$261M
Cap. Flow
-$202M
Cap. Flow %
-1.87%
Top 10 Hldgs %
9.55%
Holding
1,226
New
73
Increased
457
Reduced
388
Closed
76

Top Buys

Rank Stock Value
1
VIRT icon
Virtu Financial
VIRT
+$33.4M
2
MLAB icon
Mesa Laboratories
MLAB
+$27.4M
3
TNC icon
Tennant Co
TNC
+$19.8M
4
KWR icon
Quaker Houghton
KWR
+$18.2M
5
HLI icon
Houlihan Lokey
HLI
+$17.9M

Sector Composition

Rank Sector Weight
1 Industrials 28.27%
2 Technology 17.79%
3 Financials 14.2%
4 Consumer Discretionary 12.75%
5 Materials 8.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TRNS icon
601
Transcat
TRNS
$758M
$3.12M 0.03%
121,800
+57,000
+88% +$1.35M
RJET
602
Republic Airways Holdings
RJET
$817M
$3.1M 0.03%
30,663
+10,761
+54% +$1.31M
AVD icon
603
American Vanguard Corp
AVD
$66.7M
$3.1M 0.03%
+197,500
New +$2.9M
PRMW
604
DELISTED
Primo Water Corporation
PRMW
$3.1M 0.03%
252,040
-66,000
-21% -$855K
SRGA
605
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$3.08M 0.03%
35,989
+9,191
+34% +$981K
LXP icon
606
LXP Industrial Trust
LXP
$3.59B
$3.06M 0.03%
59,804
+1,390
+2% +$69.5K
MTG icon
607
MGIC Investment
MTG
$6.14B
$3.05M 0.03%
242,548
-20,000
-8% -$258K
MTUS icon
608
Metallus
MTUS
$793M
$3.01M 0.03%
478,157
-191,100
-29% -$1.25M
CASS icon
609
Cass Information Systems
CASS
$711M
$2.99M 0.03%
55,349
+157
+0.3% +$8.02K
CSLT
610
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$2.99M 0.03%
2,119,397
+213,153
+11% +$425K
TNDM icon
611
Tandem Diabetes Care
TNDM
$1.13B
$2.98M 0.03%
+50,500
New +$3.22M
SBR
612
Sabine Royalty Trust
SBR
$1.09B
$2.98M 0.03%
68,613
MMM icon
613
3M
MMM
$84.9B
$2.96M 0.03%
21,528
+2,392
+13% +$334K
ZUO
614
DELISTED
Zuora, Inc.
ZUO
$2.96M 0.03%
196,400
-51,600
-21% -$777K
JLL icon
615
Jones Lang LaSalle
JLL
$15.7B
$2.91M 0.03%
20,949
+2,849
+16% +$395K
EIC
616
Eagle Point Income Company
EIC
$227M
$2.9M 0.03%
+150,000
New +$2.98M
ITW icon
617
Illinois Tool Works
ITW
$76.5B
$2.9M 0.03%
18,500
VALU icon
618
Value Line
VALU
$370M
$2.89M 0.03%
126,875
-5,099
-4% -$129K
VRNS icon
619
Varonis Systems
VRNS
$5.45B
$2.88M 0.03%
144,681
+12,000
+9% +$267K
CSCO icon
620
Cisco
CSCO
$434B
$2.87M 0.03%
58,000
+500
+0.9% +$26K
WLK icon
621
Westlake Corp
WLK
$8.95B
$2.86M 0.03%
43,700
-16,400
-27% -$1.06M
PRCP
622
DELISTED
Perceptron Inc
PRCP
$2.86M 0.03%
595,561
-138,019
-19% -$621K
TTEK icon
623
Tetra Tech
TTEK
$9.4B
$2.85M 0.03%
164,110
+4,970
+3% +$81.2K
GCI
624
DELISTED
Gannett Co., Inc
GCI
$2.85M 0.03%
264,974
+23,693
+10% +$235K
PKOH icon
625
Park-Ohio Holdings
PKOH
$652M
$2.84M 0.03%
95,156
-9,500
-9% -$283K

Similar funds

Royce & Associates's Q3 2019 Portfolio in Review

As of Q3 2019, Royce & Associates held 1,226 positions worth $10.8B, down 2.4% from $11.1B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.

Royce & Associates's Q3 2019 filing shows 73 new, 457 increased, 388 reduced and 76 closed positions. Its largest new stake was Upbound Group: 521,616 shares worth $13.5M. The largest sale was John B. Sanfilippo & Son, an estimated $73.8M.

By sector, the portfolio is most concentrated in Industrials at 28% of assets, down from 29% a quarter earlier, followed by Technology and Financials.

  • Royce & Associates's largest Q3 2019 buy was Upbound Group: 521,616 shares worth $13.5M.
  • Royce & Associates added most to Virtu Financial in Q3 2019, an estimated $33.4M increase.
  • Royce & Associates's biggest Q3 2019 reduction was John B. Sanfilippo & Son, cutting an estimated $73.8M.
  • Royce & Associates fully exited Cambrex Corporation in Q3 2019, selling an estimated $14.7M.
  • Royce & Associates's ten largest holdings make up 9.6% of its $10.8B portfolio in Q3 2019.
  • Royce & Associates opened 73 new positions and closed 76 in Q3 2019.
  • Royce & Associates's portfolio value fell 2.4% quarter-over-quarter to $10.8B.

Based on Royce & Associates's 13F filing for Q3 2019, filed 13 Nov 2019.